Status:

COMPLETED

Wool Clothing for the Management of Childhood Atopic Dermatitis (DESSINE2)

Lead Sponsor:

Murdoch Childrens Research Institute

Collaborating Sponsors:

Australian Wool Innovation Ltd

Northwestern University

Conditions:

Dermatitis, Atopic

Eligibility:

All Genders

3-5 years

Phase:

NA

Brief Summary

The study is a sequentially recruited, cross-over-cohort, outpatient-based evaluation of the effectiveness of wool clothing, as compared to standard clothing, in reducing the severity of childhood ato...

Detailed Description

The study will aim for a sample size of approximately 150 participants (equally distributed between 3 international sites) between the ages of 3 months and 5 years referred to the respective Dermatolo...

Eligibility Criteria

Inclusion

  • Is aged between 3 months and 5 years of age at the time of recruitment
  • Has moderate to severe eczema as determined by an EASI score of 7 or above at their initial visit
  • Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participants behalf

Exclusion

  • Has a known allergic contact dermatitis to wool or merino wool
  • Is unable to attend all scheduled visits
  • Has unstable eczema defined by an escalation of treatment requirements during the preceding 6 weeks. This would include flares of AD for any reason including infection, food allergy etc.
  • Use of systemic corticosteroids within 6 weeks of study start.
  • Any medical reason that is considered by the principal investigator to preclude enrolment.

Key Trial Info

Start Date :

September 23 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 31 2024

Estimated Enrollment :

19 Patients enrolled

Trial Details

Trial ID

NCT04011215

Start Date

September 23 2019

End Date

October 31 2024

Last Update

May 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northwestern University, Skin Disease Research Center, Lurie Children's Hospital

Chicago, Illinois, United States, 60611